| Literature DB >> 23948934 |
David T Chien1, A Katrin Szardenings, Shadfar Bahri, Joseph C Walsh, Fanrong Mu, Chunfang Xia, William R Shankle, Alan J Lerner, Min-Ying Su, Arkadij Elizarov, Hartmuth C Kolb.
Abstract
Aggregates of hyperphosphorylated tau (PHF-tau), such as neurofibrillary tangles, are linked to the degree of cognitive impairment in Alzheimer's disease. We have recently reported early clinical results of a novel PHF-tau targeting PET imaging agent, [F18]-T807. Since then, we have investigated a second novel PHF-tau targeting PET imaging agent, [F18]-T808, with different pharmacokinetic characteristics, which may be favorable for imaging Alzheimer's disease and other tauopathies. Here, we describe the first human brain images with [F18]-T808.Entities:
Keywords: Alzheimer's disease; PHF-tau; amyloid-β; brain imaging; mild cognitive impairment; molecular imaging; neurofibrillary tangles; tau; tau aggregates; tauopathy
Mesh：
Substances：
Year: 2014 PMID： 23948934 DOI： 10.3233/JAD-130098
Source DB: PubMed Journal: J Alzheimers Dis ISSN： 1387-2877 Impact factor: 4.472